Paris, FranceSep 2021
Agalaia Therapeutics raised €4.0M in a Seed round in Sep 2021. The company is based in Paris, France. Investors in the round: Advent France Biotechnology, Crédit Mutuel Innovation, Pierre Fabre. Data as of Nov 2026.
Amount raised
€4.0M
€4,000,000
Native amount
4,000,000 EUR
Stage
Seed
seed
Investors
3
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €4.0M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Sep 2021
Round type
seed
Amount (EUR)
€4.0M
Other rounds
same companyThis is the company's only recorded round.